| |
PRODUCT NAME |
ORDER |
 |
D-Proline, ethyl ester (9CI) |
 |
 |
2,5-Pentalenedimethanol,octahydro-,(2-alpha-,3a-bta-,5-alpha-,6a-bta-)-(9CI) |
 |
 |
(S)-(-)-1-(4-Nitrophenyl)ethanol |
 |
 |
4,5-Dimethyl-3-(1-methylethyl)benzenamine |
 |
 |
4-Propylphenyl 4,-trans-butylcyclohexylbenzoate |
 |
 |
4,4,-Isopropylidenediphenol C12-15 alcohol phosphite |
 |
 |
5(4H)-Isoxazolone,4-(1-cyclopropylethylidene)-3-methyl-,(Z)-(9CI) |
 |
 |
5(4H)-Isoxazolone,4-(1-cyclopropylethylidene)-3-methyl-,(E)-(9CI) |
 |
 |
2-METHYLBUTYLAMINE |
 |
 |
2-Phenyl-5-trifluoromethyl-2H-pyrazol-3-ol |
 |
 |
2,3-dibromopropan-1-ol |
 |
 |
2,4,6-TRI-TERT-BUTYLANILINE |
 |
 |
N,N-Diethyl-3-hydrazinocarbonyl-benzenesulfonamide |
 |
 |
3-Hydrazinocarbonyl-N,N-dimethyl-benzenesulfonamide |
 |
 |
1-Piperidinecarboxylic acid, 2-hydroxy-6-methyl-, methyl ester |
 |
 |
1-Piperidinecarboxylicacid,2-hydroxy-,methylester(9CI) |
 |
 |
N-(3-METHACRYLOXY-2-HYDROXYPROPYL)-3-AMINOPROPYLTRIETHOXYSILANE; 50% IN ETHANOL |
 |
 |
3,8-Diazabicyclo[3.2.1]octane,3-butyl-8-methyl-(6CI,9CI) |
 |
 |
4,7-DICHLOROINDOLE |
 |
 |
Isoliquiritigenin |
 |
 |
2,7-Diacetylfluorene |
 |
 |
Propanedinitrile, (1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)- (9CI) |
 |
 |
1H-Pyrrolizine-3-carboxylicacid,6-aminohexahydro-5-oxo-,methylester, |
 |
 |
1H-Pyrrolizine-3-carboxylicacid,6-aminohexahydro-5-oxo-,methylester, |
 |
 |
2H-Pyrrole-2-carboxylicacid,3,4-dihydro-,methylester,1-oxide(9CI) |
 |
 |
CALIX[6]ARENE |
 |
 |
1H-TETRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER SODIUM SALT |
 |
 |
2,-Deoxyguanosine monohydrate |
 |
 |
2H-Tetrazole-5-carboxylicacid,2-methyl-,methylester(9CI) |
 |
 |
2-AMINO-3,3,3-TRIFLUOROPROPIONIC ACID HYDROCHLORIDE |
 |
 |
4-Pyrimidinecarbonitrile, 1,2-dihydro-2-oxo- (9CI) |
 |
 |
[1,2,4]Triazino[4,5-a]benzimidazol-1(2H)-one,4-methyl-(9CI) |
 |
 |
Ethanone, 1-(1H-benzimidazol-2-yl)-, hydrazone (9CI) |
 |
 |
[1,2,4]Triazino[4,5-a]benzimidazol-1(2H)-one(9CI) |
 |
 |
3-Methyl-5-trifluoromethylaniline |
 |
 |
N-Isopropyl-N-methyl-5-methoxytryptamine hydrochloride |
 |
 |
2-Furancarboxylicacid,4-amino-4,5-dihydro-(9CI) |
 |
 |
TRIPHENYLBORON |
 |
 |
3-bromo-5-chloropyrazolo[1,5-a]pyrimidine |
 |
 |
1,8-Naphthyridin-2-amine, N-1,8-naphthyridin-2-yl- |
 |
 |
methyl 2-indolinecarboxylate |
 |
 |
4-Pyridazinecarboxamide,N-hydroxy-(9CI) |
 |
 |
3-Furancarboxylic acid, 5-(4-bromophenyl)-2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]- |
 |
 |
3-Furancarboxylic acid, 2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-5-phenyl- |
 |
 |
3-Furancarboxylic acid, 2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-5-(4-pyrazolo[1,5-a]pyrimidin-2-ylphenyl)-, ethyl ester |
 |
 |
3-Furancarboxylic acid, 5-[4-(5-amino-1H-pyrazol-3-yl)phenyl]-2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-, ethyl ester |
 |
 |
3-Furancarboxylic acid, 5-[4-(2-cyanoacetyl)phenyl]-2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-, ethyl ester |
 |
 |
3-Furancarboxylic acid, 5-(4-imidazo[2,1-b]thiazol-6-ylphenyl)-2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-, ethyl ester |
 |
 |
3-Furancarboxylic acid, 2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-5-(4-oxazolo[4,5-b]pyridin-2-ylphenyl)-, ethyl ester |
 |
 |
3-Furancarboxylic acid, 5-[4-(2-benzoxazolyl)phenyl]-2-[[(trans-4-methylcyclohexyl)carbonyl](1-methylethyl)amino]-, ethyl ester |
 |